The claim there is no evidence painkillers combined with lower doses of codeine are more effective in treating pain, is misleading. As are others in this debate.
Articles on TGA
Displaying 41 - 60 of 90 articles
Would you trust a complementary medicine described as “vermifuge”, “vulnerary” or “emmenagogue”? That’s what new labelling proposes and not everyone’s happy about it.
Regulatory bodies approved some medical devices to treat pelvic organ prolapse and urinary incontinence before having data to prove their safety and efficacy.
An independent expert provides his pick of the most notable drugs added to the PBS on May 1, 2017.
If the Therapeutic Goods Administration implements new proposals to regulate complementary medicines, you can be more confident they actually do what they say on the packet.
The recent decision to effectively ban e-cigarettes will hurt poor and disadvantaged smokers the most.
E-cigarettes remain effectively banned in Australia because advocates’ evidence has failed to convince the Therapeutic Goods Administration.
Consumers can’t always be confident claims for complementary medicines stack up. Here’s how to foster truth in advertising.
The Social Medwork is a website that promises patients legal access to medicines from overseas. How does it work? What are the risks? And why are patients turning to it to access the drugs they need?
If your health practitioner has used a syringe, pacemaker, dental filling or joint implant to treat you, you’ve encountered a product from the medical technology industry.
Due to a lack of effective regulations, there is little oversight of “stem cell treatments” and the businesses that provide them.
Australians clinics are offering stem-cell-based anti-ageing and cosmetic therapies that have not been clinically tested. Here’s what we need to do to ensure consumers don’t get ripped off, or worse.
We recently submitted a complaint about the promotion of Ease-a-Cold products, which claim to be “clinically proven” to shorten your cold.
Making sure that a tablet claiming to have 500 mg of paracetamol really does contain 500 mg of paracetamol is relatively easy. But how do you test for herbs?
When asked about importing cannabis oil to treat child epilepsy, rural health minister Fiona Nash told Q&A that the TGA can allow importation of products not registered in Australia. Is that right?
Before the last round of negotiations, only a handful of issues remained in the way of concluding the TPP. A potential deal-breaker for Australia was intellectual property protections for biologics.
As part of an intiative to re-examine misrepresented or abandoned studies, we re-analysed an antidepressant trial. Here’s what we found.
The off-label use of medicines is not illegal and it doesn’t mean regulators have specifically “disapproved” its use. But there are a number of issues to consider before using a medicine off-label.
The Victorian government is calling on other state governments to join it in banning powdered alcohol, which was recently approved for marketing and sale in the US.
Once thought to be a problem only in poorly regulated jurisdictions overseas, unproven stem cell treatments are increasingly being offered in Australia. Now, the Therapeutic Goods Administration (TGA…
Top contributors
-
Health activist, Medreach Pty Ltd., Bond University
-
Professor of Pharmaceutical Chemistry, Macquarie University
-
Associate Professor, School of Law, University of Canberra
-
Professor and Deputy Director, Monash Addiction Research Centre, Monash University
-
NHMRC Postgraduate Scholar and Fulbright Alumna in Public Health Policy, Monash University
-
Associate Professor of Law, Bond University
-
Lecturer in Law, Sydney Law School, University of Sydney
-
Adjunct Associate Professor, UNSW
-
Postdoctoral Research Fellow, National Drug and Alcohol Research Centre, UNSW
-
Professor in Pharmaceutical Policy, School of Pharmacy and Charles Perkins Centre, University of Sydney
-
Associate Professor of Pharmacology, University of Sydney
-
Pharmacist and PhD Candidate, University of Sydney
-
Research Affiliate, The University of Sydney, University of Sydney
-
Clinical pharmacist and Scientia Associate Professor at the National Drug and Alcohol Research Centre, UNSW
-
Professor - Emerging Technologies (Stem Cells) at The University of Melbourne and Group Leader - Stem Cell Ethics & Policy at the Murdoch Children's Research Institute, The University of Melbourne